Aducanumab
Aducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.
Wikipage redirect
primaryTopic
Aducanumab
Aducanumab, sold under the brand name Aduhelm, is a medication used to treat Alzheimer's disease (AD). It is an amyloid beta-directed monoclonal antibody. Aducanumab targets aggregated forms of Amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup.
has abstract
Aducanumab, sold under the bra ...... treat symptoms of Alzheimer's.
@en
CAS number
1384260-65-4
FDA UNII code
105J35OE21
KEGG
Wikipage page ID
41.323.388
page length (characters) of wiki page
Wikipage revision ID
1.018.758.266
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
KEGG
D10541
@en
mab type
mab
@en
molecular weight
source
u
@en
synonyms
BIIB037
@en
target
beta amyloid
@en
type
mab
@en
wikiPageUsesTemplate
hypernym
comment
Aducanumab, sold under the bra ...... disease to reduce its buildup.
@en
label
Aducanumab
@en